2026-10-25
Does not pass
Alexander's, does not pass the ethical screen. The binding factor is interest/revenue 6.9%.
NAS100 29,403 −1.38%
S&P 7,720 −0.31%
GOLD $4,032 −0.48%
BTC $80,460 −0.99%
VIX 16.61 −1.77%
latest tape · as of 20:02 UTC
The Screen · Real Estate · REIT - Retail
Alexander's, Inc.
ALX · the NYSE · USD · Market cap $1.2B · 103 employees
Alexander's, Inc.
FAIL · Does not pass the screen250.46 USD
Price as of 26 Oct 2026Daily close, not a live quote
Screened 2026-10-26 · the tape above runs as of 20:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price250.46 USD at the 26 Oct 2026 close
- Ethical screenDoes not pass
- Last reviewed26 Oct 2026 (3 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 250.46 against the desk's fair-value range, base estimate 175.82, over the last year.
- Trend Accumulation
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Price250.46 USD
Fair value175.82
Ethical score70.0/100
Our investment reviews on this name
2026-10-24Read Accumulation232.79+7.6% to today ✓Markdown gives way to Accumulation after an 8% slide in 5 weeks
2026-09-21Read Markdown253.30-1.1% to today ✓Distribution gives way to Markdown after a 7% slide in 4 weeks
2026-08-21Read Distribution272.74-8.2% to today ✓Markup gives way to Distribution
2026-07-02Read Markup262.60-4.6% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its accumulation label.
Alexander's, Inc. holds its Accumulation at $250.46. The statistical read favours the sellers, held for 51 days.
| Phase | Accumulation |
| Quantitative state | The statistical read favours the sellers, held for 51 days |
| Price at the screen | $250.46 |
| Valuation | 7.04 trailing · 17.89 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 0.77 |
Five Screens, Shown in Full
Does not pass. Interest/revenue 6.9%
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | Excluded | Below 33% | Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | Excluded | Below 33% | Interest-bearing cash and securities are of assets, above the one-third limit. | Fail |
| Receivables | Excluded | Below 49% | Money owed to the company is of assets, above the 49% limit. | Fail |
| Revenue purity | 6.88% | Below 5% | 6.9% of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Alexander's, does not pass the ethical screen. The binding factor is interest/revenue 6.9%.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Alexander's, clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
Follow this verdict
Get an email when ALX's ethical verdict changes
Today ALX does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value range in USD, drawn from the 2026-10-26 screen. The gold marker is the market price at the same screen. The price runs 29.8% above the base estimate.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-26 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | 17.9xexpensive even after accounting for its growth |
| Trailing P/E | 7.0xvery cheap relative to earnings |
| EPS, trailing | 33.06 |
| EPS, forward | 13.01 |
| Revenue growth | +6.1%slow but positive growth |
| Profit margin | 79.1%highly profitable on every dollar of sales |
| Return on equity | 92.0%an exceptional return on shareholder capital |
| FCF yield | 3.84% |
| Dividend yield | 685.00% |
| Debt to equity | 3.83heavy leverage: higher risk if revenue softens |
| Current ratio | 16.18comfortably covers its short-term bills |
| Beta | 0.77steadier than the market |
| Short interest, float | 0.12% |
| 52-week range | 201.28 - 289.43 |
| Market cap | $1.2B |
| Employees | 103 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeALX trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-10-29
Accumulation $250.46
+7.6% Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 7.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (1 analysts) rates it none, with a mean price target of $190. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28
Accumulation $232.79
+0.0% Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (1 analysts) rates it none, with a mean price target of $190. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27
Accumulation $232.79
+0.0% Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (1 analysts) rates it none, with a mean price target of $190. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26
Accumulation $232.79
+0.0% Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (1 analysts) rates it none, with a mean price target of $190. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24
Accumulation · changed $232.79
-3.4% Entry 10
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (1 analysts) rates it none, with a mean price target of $190.
2026-10-12
Markdown $240.99
-2.4% Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (1 analysts) rates it none, with a mean price target of $190.
2026-10-02
Markdown $247.02
-2.5% Entry 8
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (1 analysts) rates it none, with a mean price target of $190.
2026-09-21
Markdown · changed $253.30
-7.1% Entry 7
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 7.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (1 analysts) rates it none, with a mean price target of $190.
2026-08-21
Distribution · changed $272.74
-3.2% Entry 6
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (1 analysts) rates it none, with a mean price target of $190.
2026-07-21
Markup $281.63
+7.2% Entry 5
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 11% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (1 analysts) rates it none, with a mean price target of $190.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Crown Castle (CCI) Tops Q3 FFO Estimates Yahoo Finance · 8d ago
- Alexander's (ALX) Stock May Be Overvalued As Its 66% Run Continues Yahoo Finance · 10d ago
- Alexander's (ALX) Faces A Valuation Test Following Its November 2 Earnings Setup Yahoo Finance · 10d ago
- Alexander’s Announces Third Quarter Earnings Release Date and Vornado Realty Trust Quarterly Conference Call Yahoo Finance · 10d ago
- A $148M Sale Masks What Alexander’s (ALX) Really Earned Insider Monkey · 15 Sep 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
CBLCBL & Associates Properties, Inc.
NTSTNETSTREIT Corp.
GTYGetty Realty Corp.
BFSSaul Centers, Inc.
IVTInvenTrust Properties Corp.
FCPTFour Corners Property Trust, Inc.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $236.70 | +13.0% | $4.50 | $1,149 | +14.9% |
| 2 months | $242.87 | +10.1% | $4.50 | $1,120 | +12.0% |
| 3 months | $241.07 | +11.0% | $4.50 | $1,128 | +12.8% |
| 6 months | $208.25 | +28.5% | $9.00 | $1,328 | +32.8% |
| 1 year | $212.25 | +26.0% | $18.00 | $1,345 | +34.5% |
| 2 years | $178.20 | +50.1% | $36.00 | $1,703 | +70.3% |
| 3 years | $144.44 | +85.2% | $54.00 | $2,226 | +122.6% |
| 5 years | $189.46 | +41.2% | $90.00 | $1,887 | +88.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ALX does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.